Spironolactone Tablet
Product Images NDC 71335-2846

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71335-2846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

FDA Label Image

Figure 1 (Spironolactone 02)

Figure 1 (Spironolactone 02)
This is a statistical comparison table showing the effects of Spironolactone versus Placebo over a period of months. The probability of the results being due to chance is less than 0.001 based on the Log-rank test. It seems to be related to a clinical trial or study evaluating the efficacy of Spironolactone.*
FDA Label Image

Figure 2 (Spironolactone 03)

FDA Label Image

Label (Lbl713352846)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.